10-Benzyl-8-fluoro-2-(4-(4-methylpiperazin-1-yl)phenoxy)-5,10-dihydro-11H-dibenzo[b,e][1,4]diazepin-11-one

ID: ALA4558528

PubChem CID: 146014465

Max Phase: Preclinical

Molecular Formula: C31H29FN4O2

Molecular Weight: 508.60

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CN1CCN(c2ccc(Oc3ccc4c(c3)C(=O)N(Cc3ccccc3)c3cc(F)ccc3N4)cc2)CC1

Standard InChI:  InChI=1S/C31H29FN4O2/c1-34-15-17-35(18-16-34)24-8-10-25(11-9-24)38-26-12-14-28-27(20-26)31(37)36(21-22-5-3-2-4-6-22)30-19-23(32)7-13-29(30)33-28/h2-14,19-20,33H,15-18,21H2,1H3

Standard InChI Key:  ZPNTXOKOIHPCLI-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 38 43  0  0  0  0  0  0  0  0999 V2000
   20.2937  -14.0511    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.1112  -14.0457    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.7207  -15.8459    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.6263  -14.6830    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4577  -15.4870    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0696  -16.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.8502  -15.7763    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.0156  -14.9683    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.4024  -14.4238    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.9749  -15.5004    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7886  -14.6995    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0027  -14.4598    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4025  -15.0243    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5934  -15.8273    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3790  -16.0591    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.9280  -13.3141    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.3861  -12.6304    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.2054  -12.6882    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.6592  -12.0054    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.2976  -11.2674    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4737  -11.2164    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.0194  -11.9000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4598  -13.3024    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.6155  -14.7899    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   23.7951  -14.7105    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   24.4103  -15.2531    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.2376  -16.0549    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.8520  -16.6014    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.6326  -16.3436    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.7952  -15.5344    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.1836  -14.9914    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.2450  -16.8837    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.0796  -17.6890    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.6874  -18.2341    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.4683  -17.9790    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.6378  -17.1737    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.0224  -16.6233    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.0821  -18.5231    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  4  1  0
  1 11  1  0
  5  3  1  0
 10  3  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
  1 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 17  1  0
  2 23  2  0
 13 24  1  0
  8 25  1  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 26  1  0
 32 33  1  0
 32 37  1  0
 33 34  1  0
 34 35  1  0
 35 36  1  0
 36 37  1  0
 29 32  1  0
 35 38  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4558528

    ---

Associated Targets(Human)

SLK Tchem Serine/threonine-protein kinase 2 (1640 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KIT Tclin Stem cell growth factor receptor (10667 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EGFR Tclin Epidermal growth factor receptor erbB1 (33727 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 508.60Molecular Weight (Monoisotopic): 508.2275AlogP: 6.27#Rotatable Bonds: 5
Polar Surface Area: 48.05Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 7.83CX LogP: 7.02CX LogD: 6.45
Aromatic Rings: 4Heavy Atoms: 38QED Weighted: 0.34Np Likeness Score: -1.15

References

1. De Clercq DJH, Heppner DE, To C, Jang J, Park E, Yun CH, Mushajiang M, Shin BH, Gero TW, Scott DA, Jänne PA, Eck MJ, Gray NS..  (2019)  Discovery and Optimization of Dibenzodiazepinones as Allosteric Mutant-Selective EGFR Inhibitors.,  10  (11): [PMID:31749909] [10.1021/acsmedchemlett.9b00381]
2. Shaikh M, Shinde Y, Pawara R, Noolvi M, Surana S, Ahmad I, Patel H..  (2022)  Emerging Approaches to Overcome Acquired Drug Resistance Obstacles to Osimertinib in Non-Small-Cell Lung Cancer.,  65  (2.0): [PMID:34323489] [10.1021/acs.jmedchem.1c00876]

Source